Overview
Fellowship: Duke Hematology–Oncology (2022-present)
Residency: Duke Internal Medicine (2020-2022)
Medical/Graduate: The University of Chicago (2012-2020)
Doctor of Philosophy in Biochemistry and Molecular Biophysics, June 2018.
Doctor of Medicine, June 2020.
Undergraduate: Yale University (2008-2012)
Bachelor of Sciences in Molecular Biophysics & Biochemistry, May 2012.
Residency: Duke Internal Medicine (2020-2022)
Medical/Graduate: The University of Chicago (2012-2020)
Doctor of Philosophy in Biochemistry and Molecular Biophysics, June 2018.
Doctor of Medicine, June 2020.
Undergraduate: Yale University (2008-2012)
Bachelor of Sciences in Molecular Biophysics & Biochemistry, May 2012.
Current Appointments & Affiliations
House Staff
Medicine, Medical Oncology,
Medicine
House Staff
Medicine,
Clinical Science Departments
Recent Publications
A first-in-class EGFR-directed KRAS G12V selective inhibitor.
Journal Article Cancer cell · October 2025 Despite KRASG12V being the second most common KRAS mutation in cancer, no direct inhibitors targeting KRASG12V have been approved. RNA interference (RNAi) has faced numerous obstacles as cancer therapeutic, including the lack of cance ... Full text CiteTumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling.
Journal Article JCI insight · June 2025 Non-small cell lung cancer (NSCLC) largely consists of lung squamous carcinoma (LUSC) and lung adenocarcinoma (LUAD). Alterations in the tumor protein p53 (TP53) and phosphatase and tensin homolog (PTEN) tumor suppressors are common in both subtypes, but t ... Full text CiteSnord67 promotes breast cancer metastasis by guiding U6 modification and modulating the splicing landscape.
Journal Article Nat Commun · May 2, 2025 Previously considered "housekeeping" genes, small nucleolar RNAs (snoRNAs) are increasingly understood to have wide-ranging functions in cancer, yet their role in metastasis has been less well studied. Here, we identify the snoRNA Snord67 as a regulator of ... Full text Link to item CiteRecent Grants
Mechanisms of the small nucleolar RNA Snord67 in breast cancer lymphatic metastasis
FellowshipPI-Fellow · Awarded by National Institutes of Health · 2026 - 2027Clinical and Therapeutic Implications of the Small Nucleolar RNA Snord67 in Breast Cancer Lymphatic Metastasis
ResearchPrincipal Investigator · Awarded by American Society of Clinical Oncology · 2024 - 2025View All Grants